Lopinavir and ritonavir for the treatment of cervix disorders
AssigneeDouglas Pharmaceuticals Limited
InventorsIan Hampson, Lynne Hampson
Life of this patent
Estimating the term…
Abstract
The present invention concerns pharmaceutical compositions formulated for topical application that are useful in the treatment of HPV-related pathologies and in particular the treatment of premalignant and malignant conditions of the cervix. The compositions comprise a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir:ritonavir is between 9:1 and 18:1.
Claims10
A pharmaceutical composition that is formulated for topical application comprising a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir:
- ritonavir is between 11:1 to 12:1.
Dependencies are inferred from the claim text.